A small window has been opened for exporters to reclaim value-added tax on overseas business entertainment following a decision in the European Court of Justice. Particularly for the UK's pharmaceutical industry, which is one of the country's biggest exporters, this could mean talking about significant amounts of money.
The case is that of Danfoss and Anglo-Swedish drug major AstraZeneca, which was heard at the European Court. In brief, UK-based AstraZeneca had provided in-house catering facilities for business meetings with international manufacturer, Danfoss. According to the ECJ, such lunches have a business purpose and therefore the VAT should be deductible.
According to Barry Stocks, VAT expert and a director with BTG Tax in Manchester, UK, it is worth looking into the case because "this judgment has given businesses a brief opportunity to recover previously unclaimed VAT input tax - potentially a significant sum of money for the region's exporters. It is a really positive decision for businesses that encourage international trade and build relationships with an international client base."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze